What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Aredia
97%DGNews: Aredia Cleared by FDA for Osteolytic Bone Metastases of Breast Cancer
97%DGNews: Aredia is cleared for marketing by FDA for use in Multiple Myeloma
93%DGNews: FDA Approves Zometa (Zoledronic Acid) For Hypercalcemia of Malignancy
91%DGNews: Canada Approves Zometa (Zoledronic Acid) For Hypercalcaemia Of Malignancy
90%DGNews: Randomized Trial Shows Ganite (Gallium Nitrate Injection) Effective When Compared with a Leading Bisphosphonate in Patients with Cancer-Related Hypercalcemia
90%DGNews: Long-Term Aredia Reduces Bone Complications In Multiple Myeloma Patients
87%DGNews: Study Finds Pain Relief for Advanced Breast Cancer Patients
85%DGNews: FDA Provides Updated Information on Bisphosphonates
84%DGNews: FDA Advisory Committee Recommends Approval of Zometa (Zoledronic Acid) for Bone Metastases
83%DGNews: Many Osteoporosis Medications Prevent Fractures, but None Is Proven Best
78%DGNews: ECCO11: Zometa (Zoledronic Acid for Injection) Reduces Bone Complications in Multiple Myeloma/Breast Cancer
74%DGNews: ASCO: Zometa (Zoledronic Acid) More Effective Than Pamidronate in Hypercalcemia of Malignancy
73%DGNews: FDA Grants Priority Review For Zometa (Zoledronic Acid) For Treatment Of Bone Metastases
72%DGNews: Possible Link Between Common Chemotherapy Drug and Jawbone Necrosis
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.